Hand–foot syndrome in sorafenib and lenvatinib treatment for advanced thyroid cancer

Objective: The aim of this study was to assess the clinical impact of hand–foot syndrome (HFS) during treatment with two multikinase inhibitors, sorafenib and lenvatinib, in a large group of patients with advanced thyroid cancer. Moreover, we looked for possible associations between HFS occurrence a...

全面介紹

書目詳細資料

Principais autores:	Elisa Minaldi, Virginia Cappagli, Loredana Lorusso, Laura Valerio, Carlotta Giani, Matilde Viglione, Laura Agate, Eleonora Molinaro, Antonio Matrone, Rossella Elisei
格式:	Artigo
語言:	Inglês
出版:	Bioscientifica 2024-08-01
叢編:	European Thyroid Journal
主題:	hand–foot syndrome lenvatinib sorafenib thyroid cancer tyrosine kinase inhibitors
在線閱讀:	https://etj.bioscientifica.com/view/journals/etj/13/4/ETJ-24-0009.xml
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!